|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
19
|
|
pubmed:dateCreated |
2009-10-2
|
|
pubmed:abstractText |
The risk of malignant transformation of oral preneoplastic lesion (OPL) is difficult to assess. DeltaNp63 is an early oncoprotein associated with mucosal tumorigenesis. The purpose of this study was to assess DeltaNp63 expression in OPL and its role as a marker of oral cancer risk.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Isotretinoin,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/PDPN protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/TP63 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Trans-Activators,
http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Vitamin A,
http://linkedlifedata.com/resource/pubmed/chemical/beta Carotene,
http://linkedlifedata.com/resource/pubmed/chemical/retinol palmitate
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
pubmed-author:DeysSS,
pubmed-author:El-NaggarAdel KAK,
pubmed-author:FanYou-HongYH,
pubmed-author:HongWaun KiWK,
pubmed-author:KimEdward SES,
pubmed-author:LeeJ JackJJ,
pubmed-author:LippmanScott MSM,
pubmed-author:MaoLiL,
pubmed-author:PapadimitrakopoulouValiV,
pubmed-author:RenHeningH,
pubmed-author:SaintignyPierreP
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
6284-91
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:19773378-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19773378-Carcinoma, Squamous Cell,
pubmed-meshheading:19773378-Female,
pubmed-meshheading:19773378-Follow-Up Studies,
pubmed-meshheading:19773378-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:19773378-Genetic Predisposition to Disease,
pubmed-meshheading:19773378-Humans,
pubmed-meshheading:19773378-Inflammation,
pubmed-meshheading:19773378-Isotretinoin,
pubmed-meshheading:19773378-Leukoplakia, Oral,
pubmed-meshheading:19773378-Male,
pubmed-meshheading:19773378-Membrane Glycoproteins,
pubmed-meshheading:19773378-Middle Aged,
pubmed-meshheading:19773378-Mouth Neoplasms,
pubmed-meshheading:19773378-Prognosis,
pubmed-meshheading:19773378-Trans-Activators,
pubmed-meshheading:19773378-Transcription Factors,
pubmed-meshheading:19773378-Tumor Markers, Biological,
pubmed-meshheading:19773378-Tumor Suppressor Proteins,
pubmed-meshheading:19773378-Up-Regulation,
pubmed-meshheading:19773378-Vitamin A,
pubmed-meshheading:19773378-beta Carotene
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia.
|
|
pubmed:affiliation |
Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, N.I.H., Extramural
|
